William L. Redmond, PhD
Earle A. Chiles Research Institute
Providence Cancer Institute
Director, Immune Monitoring Laboratory
Earle A. Chiles Research Institute
Providence Cancer Institute
Dr. Redmond joined the Earle A. Chiles Research Institute, a Providence Center of Excellence for immuno-oncology and cellular therapy, in 2004 as a post-doctoral fellow. Currently, he leads the Cancer Immunotherapy Lab and the Immune Monitoring Lab. Dr. Redmond’s research seeks to understand how immunotherapy with T cell agonists, checkpoint inhibitors, cytokines, and other novel agents synergize to augment anti-tumor immunity. Additionally, he seeks to identify biomarkers of response to treatment that may provide insight into how immunotherapy improves outcomes for patients with advanced malignancies.
Dr. Redmond is also an adjunct assistant professor in the Department of Molecular Microbiology and Immunology at Oregon Health & Science University.
The Cancer Immunotherapy Lab’s goal is to determine how immunotherapy with T cell agonists, such as anti-OX40; common gamma chain cytokines, such as interleukin-2; and immune checkpoint blockade, such as anti-PD-1 and anti-CTLA-4; synergize with therapies - including galectin-3 inhibitors, radiation therapy, chemotherapy, and/or tumor-specific vaccines - to boost T cell function and cause tumor regression. Ultimately, understanding how immunotherapies enable tumor-reactive T cells to destroy tumors will help guide the development of novel and more effective cancer therapies.
- Post doctoral Immunology, Earle A. Chiles Research Institute, Providence Cancer Institute, 2009
- Doctor of Philosophy, Immunology, The Scripps Research Institute, 2004
- Bachelor of Science, Biology, University of California at Davis, 1997
- Member, Laboratory of Cancer Immunotherapy, Earle A. Chiles Research Institute, Providence Cancer Institute, 2021-present
- Director, Immune Monitoring Laboratory, Earle A. Chiles Research Institute, Providence Cancer Institute, 2016-present
- Associate member, Laboratory of Cancer Immunotherapy, Earle A. Chiles Research Institute, Providence Cancer Institute, 2015-2021
- Adjunct assistant professor, Oregon Health & Science University, Department of Molecular Microbiology and Immunology, 2012-present
- Assistant member, Laboratory of Cancer Immunotherapy, Earle A. Chiles Research Institute, Providence Cancer Institute, 2009-2015
- Post-doctoral fellow, Earle A. Chiles Research Institute, Providence Cancer Institute, 2004-2009
- American Association for Cancer Research
- American Association of Immunologists (AAI)
- Society for Immunotherapy of Cancer (SITC)
- SITC Team Science Award, 2020
- Susan G. Komen – Career Catalyst Research Grant, 2015-2018
- V Foundation – V Scholar Award, 2011-2013
- Junior Faculty Travel Grant and Cynthia Chambers Memorial - eBioscience Junior Faculty Award, AAI Annual Meeting, San Francisco, Calif., 2011
- NIH/NCI – Pathway to Independence Award (K99), 2010-2014
- Prostate Cancer Foundation – Young Investigator Award, 2008-2011
- American Cancer Society – Sam E. and Kathleen L. Henry Postdoctoral Fellowship, 2006-2009
- Trainee Abstract Award, AAI Annual Meeting, Seattle, Wash., 2009
- Trainee Abstract Award, AAI Annual Meeting, San Diego, Calif., 2008
- Achievement Rewards for College Scientists (ARCS) Foundation – Scholar, Pre-doctoral Fellowship, 2001-2004
Dr. Redmond’s research is published in peer-reviewed scientific and medical journals. He has collaborated with colleagues on various research projects.